About Rho GTPase-activating protein 8
Rho GTPase-activating protein 8 (ARHGAP8) is a protein
from Homo sapiens identified by UniProt accession
P85298, 464 residues long.
MolForge cross-references it against 0 known binders and
63 disease associations.
Target properties
| Protein name | Rho GTPase-activating protein 8 |
| UniProt accession | P85298 |
| Gene | ARHGAP8 |
| Organism | Homo sapiens |
| Length | 464 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (63)
Diseases linked to this target (Open Targets).
- binge eating · score 0.31
- neurofibrillary tangles measurement · score 0.30
- metabolite measurement · score 0.09
- early-onset non-syndromic cataract · score 0.07
- Cataract-microcornea syndrome · score 0.06
- Total congenital cataract · score 0.06
- isolated ectopia lentis · score 0.06
- Cataract with Y-shaped suture opacities · score 0.05
- Anterior polar cataract · score 0.05
- Posterior polar cataract · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P85298-F1 | alphafold | PREDICTED | 75.78 | — |
Amino-acid sequence (464 residues)
MAGQDPALST SHPFYDVARH GILQVAGDDR FGRRVVTFSC CRMPPSHELD HQRLLEYLKY TLDQYVENDY TIVYFHYGLN SRNKPSLGWL QSAYKEFDRK DGDLTMWPRL VSNSKLKRSS HLSLPKYWDY RYKKNLKALY VVHPTSFIKV LWNILKPLIS HKFGKKVIYF NYLSELHEHL KYDQLVIPPE VLRYDEKLQS LHEGRTPPPT KTPPPRPPLP TQQFGVSLQY LKDKNQGELI PPVLRFTVTY LREKGLRTEG LFRRSASVQT VREIQRLYNQ GKPVNFDDYG DIHIPAVILK TFLRELPQPL LTFQAYEQIL GITCVESSLR VTGCRQILRS LPEHNYVVLR YLMGFLHAVS RESIFNKMNS SNLACVFGLN LIWPSQGVSS LSALVPLNMF TELLIEYYEK IFSTPEAPGE HGLAPWEQGS RAAPLQEAVP RTQATGLTKP TLPPSPLMAA RRRL
Explore Rho GTPase-activating protein 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets